Posted in Brexit, International Trade & Investment Law, Litigation, Miscellaneous

Dutch lawyer warns companies against using British system for disputes

Dutch courts are less expensive, more tech-savvy and less burdensome then British courts when it comes to litigation.

Considering the uncertianty generated by rexit and the upcoming NCC (Dutch Commercial Court), as well as worldwide reputation and heuight in justive rankings and efficiency, why turning to UK courts?


Posted in HealthCare Law, International Trade & Investment Law, Tax Law

Election Results 2016: Preliminary Considerations for the Drug and Device Industry

  1. Repeal/replace the Obamacare
  2. Medicaid to become a pro-capita capped, individual state program where a defined number of beneficiaries will qualify for benefits.
  3. address Drugs’ price increase (by foreign imports or imposing duties of transparency?)
  4. lowering corporate tax from 35% to 15% (kaboom) and 10% of repatriation tax.